Literature DB >> 12080065

Primates highly responsive to dietary cholesterol up-regulate hepatic ACAT2, and less responsive primates do not.

Lawrence L Rudel1, Matthew Davis, Janet Sawyer, Ramesh Shah, Jeanne Wallace.   

Abstract

The role of liver acyl-CoA:cholesterol acyltransferase 2 (ACAT2), earlier shown to be the principal ACAT enzyme within primate hepatocytes, as a regulator of the hypercholesterolemia induced by dietary cholesterol was studied. At the end of low and high cholesterol diet periods, liver biopsies were taken from cynomolgus monkeys, a species highly responsive to dietary cholesterol, and less responsive African green monkeys. Liver cholesterol and cholesteryl ester concentrations were highest in cynomolgus monkeys fed cholesterol, despite the fact that in order to induce equivalent hypercholesterolemia, dietary cholesterol levels were 50% lower than was fed to green monkeys. Hepatic cholesteryl oleate secretion rate, measured during liver perfusion as an indicator of ACAT activity, was significantly higher in cynomolgus monkeys. Liver microsomal ACAT activity was 2-3-fold higher in cynomolgus monkeys than in green monkeys. The responses of ACAT2 were compared with those of ACAT1 that is found primarily in Kupffer cells. ACAT2 protein mass was significantly correlated to microsomal total ACAT activity in both species; ACAT1 mass was less well correlated. Dietary cholesterol induced a significant 3-fold increase of ACAT2 protein mass in cynomolgus monkeys, a much greater increase than was found for mRNA abundance; neither ACAT2 mRNA nor protein was diet-responsive in green monkeys. In cynomolgus monkeys but not in green monkeys, liver free cholesterol concentrations were elevated when cholesterol was fed and were correlated with ACAT2 protein levels. The data suggest a mechanism whereby the elevation of hepatic free cholesterol concentrations by dietary cholesterol, seen only in cynomolgus monkeys, resulted in higher ACAT2 protein levels in hepatocytes, either through increased production or stabilization of the protein. Regulation of ACAT2 gene transcription was not a factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080065     DOI: 10.1074/jbc.M204106200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  ACAT inhibition and amyloid beta reduction.

Authors:  Raja Bhattacharyya; Dora M Kovacs
Journal:  Biochim Biophys Acta       Date:  2010-04-14

2.  Acute P-407 administration to mice causes hypercholesterolemia by inducing cholesterolgenesis and down-regulating low-density lipoprotein receptor expression.

Authors:  Carlos Leon; Kishor M Wasan; Kristina Sachs-Barrable; Thomas P Johnston
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

3.  Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice.

Authors:  Lauren Hager; Lixin Li; Henry Pun; Lu Liu; Mohammad A Hossain; Graham F Maguire; Mark Naples; Chris Baker; Lilia Magomedova; Jonathan Tam; Khosrow Adeli; Carolyn L Cummins; Philip W Connelly; Dominic S Ng
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

4.  Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization.

Authors:  Heather M Alger; J Mark Brown; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Mark C Willingham; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

5.  Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Emily L Willner; Bryan Tow; Kimberly K Buhman; Martha Wilson; David A Sanan; Lawrence L Rudel; Robert V Farese
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

6.  Identification of the interaction site within acyl-CoA:cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A.

Authors:  Akash Das; Matthew A Davis; Hiroshi Tomoda; Satoshi Omura; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

7.  Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.

Authors:  Paolo Parini; Ulf Gustafsson; Matt A Davis; Lilian Larsson; Curt Einarsson; Martha Wilson; Mats Rudling; Hiroshi Tomoda; Satoshi Omura; Staffan Sahlin; Bo Angelin; Lawrence L Rudel; Mats Eriksson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-13       Impact factor: 8.311

8.  Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons.

Authors:  David L Rainwater; Laura A Cox; Jeffrey Rogers; John L VandeBerg; Michael C Mahaney
Journal:  J Lipid Res       Date:  2009-03-08       Impact factor: 5.922

9.  Identification of candidate genes encoding an LDL-C QTL in baboons.

Authors:  Genesio M Karere; Jeremy P Glenn; Shifra Birnbaum; Sassan Hafizi; David L Rainwater; Michael C Mahaney; John L VandeBerg; Laura A Cox
Journal:  J Lipid Res       Date:  2013-04-17       Impact factor: 5.922

10.  Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys.

Authors:  Kylie Kavanagh; Matthew A Davis; Li Zhang; Martha D Wilson; Thomas C Register; Michael R Adams; Lawrence L Rudel; Janice D Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.